Introduction
The formulary has been developed, organized and is administered to
promote rational, clinically appropriate, safe and cost effective drug
All FDA-approved generic medications are included in the formulary
unless safety or efficacy information warrants further consideration.
Therefore, the formulary management and development process
primarily considers single-source and multi-source brand (collectively,
Brands ) medications for which no generic equivalent is available.
Not all classes of drugs are managed by this formulary. This is due
several factors such as the number of branded competitive products,
generic product availability and utilization patterns. The number of
managed drug classes may increase or decrease due to these
factors (unless otherwise excluded under your drug benefit design),
the brand name drug within that drug class is considered a formulary
New drugs approved by the FDA will be considered as non-formulary,
third-tier co-payment until such time as the drug is reviewed for
formulary consideration and placement.
The preferred Drug formulary will not supersede any coverage limitations
included in your Benefit Design or appropriate use or utilization
management programs that may be applicable to your benefit. SPECIALTY PHARMACY
Your health plan requires that selected drugs be dispensed by the
*Indicates a generic equivalent for the brand drug is available
Contents Introduction Formulary Allergy Asthma Inhaled Oral Bronchodilators/CorticosteroidsAnitbiotics, Macrolide/KetolidesAntibiotics, FluroquinolonesInsomnia/Sleeping Aids, NonbenzodiazepinesAntinauseantsHeartburn/Ulcer Agents/Proton Pump InhibitorsLong Acting Narcotic AnalgesicsRhematoid Arthritis Agents, InjectableOveractive Bladder AgentsProstate AgentsGeneric Copay Brand Copay Non Formulary Copay Allergy/Asthma Antihistamines Inhaled Allergy (Nasal) Inhaled Corticosteroids (Oral) Inhaled Broncodilators (Oral) Inhaled Bronchodilators/Corticosteroids Leukotriene Modifiers Generic Copay Brand Copay Non Formulary Copay Anti-Infectives Beta-Lactams Macrolides/Ketolides Fluroquinolones Antiviral, Antiherpes Antiviral, HEP C
NOTE: HEP C Agents may be provided by Specialty Pharmacy Program &
Generic Copay Brand Copay Non Formulary Copay Cardiovascular ACE Inhibitors Angiotensin Receptor Blockers (ARBS) Beta Blockers Calcium Channel Blockers Cholesterol Management Agents Generic Copay Brand Copay Non Formulary Copay Central Nervous System Alzheimers Agents
Goto, G.H. Katayama, H. Tanigaki, Y. Fushiki, S. Nishizawa, Y and Nishizawa, Y. (2008) Methylcobalamin inhibits fibroblast growth factor-8 stimulated proliferation and induces apoptosis in Shionogi carcinoma cells. Int. J. Vitam. Nutr. Res., 78, 21-26 Kataoka, T. Tsukamoto, Y. Matsumura, M. Miyake, A. Kamiura, S. Ishiguro, S. and Nishizawa, Y. (2008) Expression of p21Cip1/Waf1 and p27Kip1 in s
Accommodation at The Sidings, Penryn The Sidings provides contemporary student accommodation for 233 students from both the University of Exeter (Cornwall Campus) and University College Falmouth. The residence is managed by CRM, the market leader in the management of student accommodation across the country. It is conveniently located within a short walk from both the Tremough Campus a